Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$13.36 - $18.94 $2.41 Million - $3.41 Million
-180,243 Reduced 2.11%
8,357,301 $116 Million
Q1 2024

May 01, 2024

SELL
$15.65 - $19.45 $6.01 Million - $7.47 Million
-383,919 Reduced 4.3%
8,537,544 $153 Million
Q4 2023

Jan 26, 2024

SELL
$12.12 - $18.19 $3.27 Million - $4.91 Million
-269,667 Reduced 2.93%
8,921,463 $157 Million
Q3 2023

Nov 13, 2023

SELL
$13.9 - $19.58 $2.79 Million - $3.93 Million
-200,847 Reduced 2.14%
9,191,130 $134 Million
Q2 2023

Jul 28, 2023

SELL
$16.89 - $24.64 $1.81 Million - $2.63 Million
-106,869 Reduced 1.13%
9,391,977 $171 Million
Q1 2023

May 03, 2023

SELL
$15.9 - $24.72 $11.5 Million - $17.9 Million
-724,963 Reduced 7.09%
9,498,846 $229 Million
Q4 2022

Jan 24, 2023

SELL
$10.7 - $17.84 $6.93 Million - $11.5 Million
-647,325 Reduced 5.95%
10,223,809 $164 Million
Q3 2022

Oct 27, 2022

SELL
$12.84 - $24.13 $4.11 Million - $7.72 Million
-319,755 Reduced 2.86%
10,871,134 $144 Million
Q2 2022

Aug 08, 2022

SELL
$16.75 - $22.54 $3.96 Million - $5.33 Million
-236,394 Reduced 2.07%
11,190,889 $240 Million
Q1 2022

May 05, 2022

SELL
$17.89 - $28.73 $20 Million - $32.1 Million
-1,117,785 Reduced 8.91%
11,427,283 $245 Million
Q4 2021

Jan 20, 2022

SELL
$26.1 - $45.21 $2.82 Million - $4.88 Million
-107,947 Reduced 0.85%
12,545,068 $357 Million
Q3 2021

Oct 19, 2021

BUY
$24.46 - $38.41 $290 Million - $456 Million
11,865,551 Added 1506.81%
12,653,015 $419 Million
Q1 2021

May 06, 2021

BUY
$25.58 - $39.0 $20.1 Million - $30.7 Million
787,464 New
787,464 $21.5 Million

Others Institutions Holding CERT

About Certara, Inc.


  • Ticker CERT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 159,899,008
  • Market Cap $2.08B
  • Description
  • Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company al...
More about CERT
Track This Portfolio

Track Baillie Gifford & CO Portfolio

Follow Baillie Gifford & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.